{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T17:38:33Z","timestamp":1786642713330,"version":"build-2736575974"},"reference-count":34,"publisher":"MDPI AG","issue":"16","license":[{"start":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T00:00:00Z","timestamp":1786579200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Clin. Med.","JCM"],"abstract":"<jats:p>Background: Computed tomography (CT)-derived body composition has emerged as a promising prognostic biomarker in pancreatic ductal adenocarcinoma (PDAC). However, most previous studies have relied on baseline measurements and evaluated either resected or metastatic disease separately. We aimed to investigate the prognostic significance of both baseline and longitudinal CT-derived body composition changes in clinically distinct but therapeutically homogeneous cohorts of patients with PDAC receiving FOLFIRINOX. Methods: This retrospective single-center study included 98 consecutive patients with histologically confirmed PDAC treated with FOLFIRINOX between 2018 and 2025. Forty-seven patients underwent curative-intent resection followed by adjuvant modified FOLFIRINOX, whereas 51 patients with unresectable metastatic disease received first-line FOLFIRINOX. Skeletal muscle index (SMI) and visceral adipose tissue (VAT) were quantified on serial CT scans obtained at the third lumbar vertebral level before treatment and during therapy. Follow-up CT scans suitable for longitudinal body composition analysis were available for 46 of 51 patients (90.2%) in the metastatic cohort. Overall survival (OS), disease-free survival (DFS), and progression-free survival (PFS) were estimated using the Kaplan\u2013Meier method. Univariable and multivariable Cox proportional hazards regression analyses were performed to identify independent prognostic factors. Results: Baseline CT-derived body composition parameters were not independently associated with survival in either cohort. In the resected cohort, preservation of visceral adiposity during treatment (follow-up VAT &gt; 100 cm2) independently predicted improved OS in a multivariable model including three covariates (HR 0.460, 95% CI 0.220\u20130.960; p = 0.039). Median DFS and OS were 11.7 months (95% CI 6.5\u201316.9) and 20.9 months (95% CI 12.1\u201329.7), respectively. In the metastatic cohort, treatment-related skeletal muscle loss (\u0394SMI) independently predicted inferior OS in a multivariable model including four covariates (HR 0.949, 95% CI 0.913\u20130.986; p = 0.008), while lung metastasis was also independently associated with worse survival (HR 5.792, 95% CI 1.880\u201317.841; p = 0.002). Median PFS and OS were 9.7 months (95% CI 8.0\u201311.4) and 12.7 months (95% CI 9.9\u201315.5), respectively. Conclusions: Longitudinal CT-derived body composition changes may provide additional prognostic information beyond baseline measurements in patients with PDAC receiving FOLFIRINOX. Preservation of visceral adiposity was associated with improved survival following curative-intent resection, whereas greater treatment-related skeletal muscle loss was associated with poorer survival in metastatic disease. These findings suggest that the prognostic relevance of body composition may vary according to disease stage and should be considered hypothesis-generating pending validation in larger prospective multicenter studies.<\/jats:p>","DOI":"10.3390\/jcm15166282","type":"journal-article","created":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T17:01:35Z","timestamp":1786640495000},"page":"6282","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Stage-Specific Prognostic Impact of Longitudinal Body Composition Changes in Patients with Pancreatic Ductal Adenocarcinoma Treated with FOLFIRINOX: A Dual-Cohort Study"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8162-8294","authenticated-orcid":false,"given":"Ahmet","family":"Demirel","sequence":"first","affiliation":[{"name":"Division of Medical Oncology, Department of Internal Medicine, Marmara University Faculty of Medicine, Marmara University Pendik Training and Research Hospital, Istanbul 34854, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bora","family":"\u0130nce\u00f6z","sequence":"additional","affiliation":[{"name":"Division of Medical Oncology, Department of Internal Medicine, Marmara University Faculty of Medicine, Marmara University Pendik Training and Research Hospital, Istanbul 34854, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3562-5006","authenticated-orcid":false,"given":"Ali Kaan","family":"G\u00fcren","sequence":"additional","affiliation":[{"name":"Division of Medical Oncology, Department of Internal Medicine, Marmara University Faculty of Medicine, Marmara University Pendik Training and Research Hospital, Istanbul 34854, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Burak","family":"Pa\u00e7ac\u0131","sequence":"additional","affiliation":[{"name":"Division of Medical Oncology, Department of Internal Medicine, Marmara University Faculty of Medicine, Marmara University Pendik Training and Research Hospital, Istanbul 34854, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8994-2904","authenticated-orcid":false,"given":"Erkam","family":"Kocaaslan","sequence":"additional","affiliation":[{"name":"Division of Medical Oncology, Department of Internal Medicine, Marmara University Faculty of Medicine, Marmara University Pendik Training and Research Hospital, Istanbul 34854, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1537-3032","authenticated-orcid":false,"given":"Mustafa Alperen","family":"Tun\u00e7","sequence":"additional","affiliation":[{"name":"Division of Medical Oncology, Department of Internal Medicine, Marmara University Faculty of Medicine, Marmara University Pendik Training and Research Hospital, Istanbul 34854, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7969-9464","authenticated-orcid":false,"given":"F\u0131rat","family":"Akag\u00fcnd\u00fcz","sequence":"additional","affiliation":[{"name":"Division of Medical Oncology, Department of Internal Medicine, Marmara University Faculty of Medicine, Marmara University Pendik Training and Research Hospital, Istanbul 34854, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emek","family":"Kaya","sequence":"additional","affiliation":[{"name":"Division of Medical Oncology, Department of Internal Medicine, Marmara University Faculty of Medicine, Marmara University Pendik Training and Research Hospital, Istanbul 34854, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Canan","family":"\u00c7im\u015fit","sequence":"additional","affiliation":[{"name":"Division of Medical Oncology, Department of Internal Medicine, Marmara University Faculty of Medicine, Marmara University Pendik Training and Research Hospital, Istanbul 34854, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naz\u0131m Can","family":"Demircan","sequence":"additional","affiliation":[{"name":"Division of Medical Oncology, Department of Internal Medicine, Marmara University Faculty of Medicine, Marmara University Pendik Training and Research Hospital, Istanbul 34854, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0481-1084","authenticated-orcid":false,"given":"\u0130brahim Vedat","family":"Bayo\u011flu","sequence":"additional","affiliation":[{"name":"Division of Medical Oncology, Department of Internal Medicine, Marmara University Faculty of Medicine, Marmara University Pendik Training and Research Hospital, Istanbul 34854, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,8,13]]},"reference":[{"key":"ref_1","first-page":"10","article-title":"Cancer statistics, 2025","volume":"75","author":"Siegel","year":"2025","journal-title":"CA Cancer J. Clin."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1056\/NEJMoa1809775","article-title":"FOLFIRINOX or gemcitabine as adjuvant therapy for pancreatic cancer","volume":"379","author":"Conroy","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1056\/NEJMoa1011923","article-title":"FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer","volume":"364","author":"Conroy","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S1470-2045(10)70218-7","article-title":"Definition and classification of cancer cachexia: An international consensus","volume":"12","author":"Fearon","year":"2011","journal-title":"Lancet Oncol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1139\/H08-075","article-title":"A practical and precise approach to quantification of body composition in cancer patients using computed tomography images acquired during routine care","volume":"33","author":"Mourtzakis","year":"2008","journal-title":"Appl. Physiol. Nutr. Metab."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1152\/jappl.1998.85.1.115","article-title":"Cadaver validation of skeletal muscle measurement by magnetic resonance imaging and computerized tomography","volume":"85","author":"Mitsiopoulos","year":"1998","journal-title":"J. Appl. Physiol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1200\/JCO.2012.45.2722","article-title":"Cancer cachexia in the age of obesity: Skeletal muscle depletion is a powerful prognostic factor, independent of body mass index","volume":"31","author":"Martin","year":"2013","journal-title":"J. Clin. Oncol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"17105","DOI":"10.1038\/nrdp.2017.105","article-title":"Cancer-associated cachexia","volume":"4","author":"Baracos","year":"2018","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1080\/07853890.2018.1511918","article-title":"Implications of low muscle mass across the continuum of care: A narrative review","volume":"50","author":"Prado","year":"2018","journal-title":"Ann. Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s12957-024-03310-y","article-title":"Association between preoperative sarcopenia and prognosis of pancreatic cancer after curative-intent surgery: A updated systematic review and meta-analysis","volume":"22","author":"Liu","year":"2024","journal-title":"World J. Surg. Oncol."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"L\u00e1inez Ramos-Bossini, A.J., G\u00e1mez Mart\u00ednez, A., Luengo G\u00f3mez, D., Valverde-L\u00f3pez, F., Melguizo, C., and Prados, J. (2024). Prevalence of Sarcopenia Determined by Computed Tomography in Pancreatic Cancer: A Systematic Review and Meta-Analysis of Observational Studies. Cancers, 16.","DOI":"10.3390\/cancers16193356"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Pecchi, A., Valoriani, F., Cuoghi Costantini, R., Squecco, D., Spallanzani, A., D\u2019Amico, R., Dominici, M., Di Benedetto, F., Torricelli, P., and Menozzi, R. (2024). Role of Body Composition in Patients with Resectable Pancreatic Cancer. Nutrients, 16.","DOI":"10.3390\/nu16121834"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1002\/jcsm.13437","article-title":"Prognostic value of initial and longitudinal changes in body composition in metastatic pancreatic cancer","volume":"15","author":"Lee","year":"2024","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"982","DOI":"10.14309\/ajg.0000000000003896","article-title":"Association Between Computed Tomography-Based AI-Derived Body Composition and Survival in Patients with Pancreatic Ductal Adenocarcinoma","volume":"121","author":"Wijsman","year":"2026","journal-title":"Am. J. Gastroenterol."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Kong, H.H., Kim, K.W., Ko, Y.S., Kim, S.C., Lee, J.H., Song, K.B., Hwang, D.W., and Kim, W. (2021). Longitudinal Changes in Body Composition of Long-Term Survivors of Pancreatic Head Cancer and Factors Affecting the Changes. J. Clin. Med., 10.","DOI":"10.3390\/jcm10153436"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Supe, L., and Rizzo, S. (2026). The Correlation of Computed Tomography (CT)-Based Body Composition and Survival in Pancreatic Cancer Patients: A Systematic Review. Tomography, 12.","DOI":"10.37766\/inplasy2026.1.0026"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Rizzo, S., Scala, I., Robayo, A.R., Cefal\u00ec, M., De Dosso, S., Cappio, S., Xhepa, G., and Del Grande, F. (2022). Body composition as a predictor of chemotherapy-related toxicity in pancreatic cancer patients: A systematic review. Front. Oncol., 12.","DOI":"10.3389\/fonc.2022.974116"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.ajcnut.2025.05.022","article-title":"Methodological standards for body composition\u2014An expert-endorsed guide for research and clinical applications: Levels, models, and terminology","volume":"122","author":"Prado","year":"2025","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.ygyno.2020.10.015","article-title":"Visceral obesity and muscle mass determined by CT scan and surgical outcome in patients with advanced ovarian cancer. A retrospective cohort study","volume":"160","author":"Heus","year":"2021","journal-title":"Gynecol. Oncol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S1470-2045(08)70153-0","article-title":"Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: A population-based study","volume":"9","author":"Prado","year":"2008","journal-title":"Lancet Oncol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"6973","DOI":"10.1158\/1078-0432.CCR-09-1525","article-title":"Sarcopenia in an overweight or obese patient is an adverse prognostic factor in pancreatic cancer","volume":"15","author":"Tan","year":"2009","journal-title":"Clin. Cancer Res."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/j.clnu.2015.08.005","article-title":"The impact of sarcopenia and myosteatosis on outcomes of unresectable pancreatic cancer or distal cholangiocarcinoma","volume":"35","author":"Rollins","year":"2016","journal-title":"Clin. Nutr."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1001\/jamaoncol.2018.0137","article-title":"Association of muscle and adiposity measured by computed tomography with survival in patients with nonmetastatic breast cancer","volume":"4","author":"Caan","year":"2018","journal-title":"JAMA Oncol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1038\/nrc3829","article-title":"Cancer cachexia: Understanding the molecular basis","volume":"14","author":"Busquets","year":"2014","journal-title":"Nat. Rev. Cancer"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1161\/CIRCULATIONAHA.111.067264","article-title":"Body Fat Distribution and Risk of Cardiovascular Disease","volume":"126","year":"2012","journal-title":"Circulation"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1245\/s10434-014-4285-2","article-title":"Characterization of anthropometric changes that occur during neoadjuvant therapy for potentially resectable pancreatic cancer","volume":"22","author":"Cooper","year":"2015","journal-title":"Ann. Surg. Oncol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1007\/s11605-012-1923-5","article-title":"Impact of sarcopenia on outcomes following resection of pancreatic adenocarcinoma","volume":"16","author":"Peng","year":"2012","journal-title":"J. Gastrointest. Surg."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1096\/fj.03-0610com","article-title":"Multiple types of skeletal muscle atrophy involve a common program of changes in gene expression","volume":"18","author":"Lecker","year":"2004","journal-title":"FASEB J."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/nrendo.2012.49","article-title":"Muscles, exercise and obesity: Skeletal muscle as a secretory organ","volume":"8","author":"Pedersen","year":"2012","journal-title":"Nat. Rev. Endocrinol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1016\/j.ajpath.2012.12.023","article-title":"Autophagic degradation contributes to muscle wasting in cancer cachexia","volume":"182","author":"Penna","year":"2013","journal-title":"Am. J. Pathol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1200\/JCO.2015.63.6043","article-title":"Loss of muscle mass during chemotherapy is predictive for poor survival of patients with metastatic colorectal cancer","volume":"34","author":"Versteeg","year":"2016","journal-title":"J. Clin. Oncol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"2898","DOI":"10.1016\/j.clnu.2021.02.005","article-title":"ESPEN practical guideline: Clinical Nutrition in cancer","volume":"40","author":"Muscaritoli","year":"2021","journal-title":"Clin. Nutr."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1002\/jcsm.13478","article-title":"Body weight and composition endpoints in cancer cachexia clinical trials: Systematic Review 4 of the cachexia endpoints series","volume":"15","author":"Brown","year":"2024","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1002\/jcsm.12573","article-title":"Evaluation of automated computed tomography segmentation to assess body composition and mortality associations in cancer patients","volume":"11","author":"Popuri","year":"2020","journal-title":"J. Cachexia Sarcopenia Muscle"}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/16\/6282\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T17:11:49Z","timestamp":1786641109000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/16\/6282"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,13]]},"references-count":34,"journal-issue":{"issue":"16","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["jcm15166282"],"URL":"https:\/\/doi.org\/10.3390\/jcm15166282","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,13]]}}}